Clinical Trials Logo
  1. Home
  2. Rectal Cancer
  3. NCT04896879
  4. Details
NCT04896879 Clinical Trial

Experiences and Needs of Patients, Their Informal Caregiver and Healthcare Professionals Regarding LARS

Rectal Cancer Clinical Trial

Official title:
Rectal Cancer Survivorship, the Struggle of the Low Anterior Resection Syndrome (LARS). Experiences and Needs of Patients, Their Informal Caregiver and Healthcare Professionals

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04896879
Other study ID # EC2016/1016
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 22, 2016
Est. completion date December 31, 2020

Study information
Verified date May 2021
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Exploration of the experiences and needs of patients with the low anterior resection syndrome, their informal caregiver and health care professionals. This is a qualitative study where semi-structured interviews will be conducted with patients and informal caregivers. next to that focus groups will be performed with healthcare professionals from different professions.

Recruitment information / eligibility
Status Completed
Enrollment 69
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility PATIENTS Inclusion Criteria: - adult patients (18+) - confronted with major low anterior resection syndrome after rectal cancer surgery Exclusion Criteria: - stoma at time interview - abdominal perineal resection INFORMAL CAREGIVERS Inclusion criteria - Adults (18+) - Nominated by the participating patient as their principal caregiver Exclusion criteria None HEALTHCARE PROFESSIONALS inclusion criteria - Adults (18+) - Caring for patients with LARS Exclusion criteria None

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• interviews
semi-structured interviews will be conducted in patients with major LARS and their informal caregiver to explore their experiences and needs. Focus groups will be perfomed with healthcare professionals of several professions.

Locations
Country Name City State
n/a

Sponsors (5)
Lead Sponsor Collaborator
University Hospital, Ghent AZ Delta, AZ Sint-Jan AV, AZ Sint-Lucas Gent, Kom Op Tegen Kanker

Outcome
Type Measure Description Time frame Safety issue
Primary needs and experiences of patients with major lars and their informal caregiver through individual semistructered interviews Exploring needs and experiences of patients with major lars and their informal caregiver through individual semistructured interviews Interview will last about 60 minutes
Primary Needs and experiences of healthcare professionals caring for patients with LARS through focus groups Exploring needs and experiences of healthcare professionals caring for patients with LARS Focus group will last about 60 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1